Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Open this folder and view contents7. The editorial process
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Close this folder11. Organizational and legal issues
View the document11.1 Introduction
View the document11.2 Why does a drug bulletin need a structure?
Open this folder and view contents11.3 Different kind of structures
View the document11.4 How to deal with legal action
Close this folder11.5 Copyright
View the document11.5.1 Limits to copyright
View the document11.5.2 How is copyright created?
View the document11.5.3 How to use copyrighted material
View the document11.5.4 Fair use and quotes
View the document11.6 Further reading
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information
 

11.5.2 How is copyright created?

Copyright is created the very moment a work assumes a tangible form. As soon as the article is written and it is an original creation - not a copy of someone else’s work - copyright exists. This includes the draft of an article.

Copyright is automatic. The creator or author becomes the owner. Exceptions to this rule are when an employee in the course of his or her employment creates a work, if the work is commissioned and the commissioning party owns the copyright, and if the copyright is sold to another party. Some countries only allow human beings who created the work to establish copyrights because only real persons can create. A legal entity has to acquire or buy the rights and cannot be seen as the original author. Drug bulletins need to ask outside authors to assign the copyright of an article they have written to the bulletin, for example by buying the copyright. It is a good idea to do this as soon as the draft is received to prevent the author from withdrawing the text. For example, the letter to an author who has agreed to write the first draft of an article for the UK Drug and Therapeutics Bulletin states “We will circulate the draft to various specialists in the field, to our Advisory Council and Editorial Board and to the manufacturers of any drugs named. The draft will be edited and probably changed a lot in the light of all the comments. All our articles are the result of such collaboration and are therefore published unsigned. For this reason, Consumers' Association will have copyright in the article from the ‘circulation draft’ stage to publication”.

To strengthen the right, the author or bulletin can mark the publication with a copyright notice: © followed by the name of the copyright owner and the year of first publication. This is the international notice of claim, which was established by the Universal Copyright Convention of 1952 administered by UNESCO. If a publication carries the copyright notice, an infringing party can never claim not to have been aware of the copyright. In some countries copyright laws require this notice to inform the public that a copyright is claimed. In some countries it is also possible to register work with a national copyright office. There is usually a fee.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 20, 2014